OROS-Methylphenidate

methylphenidate, osmotic release formulation · Johnson & Johnson Taiwan Ltd

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for OROS-Methylphenidate, covering 2010-04-28 to 2013-07-31. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]

See pricing